SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-22-181642
Filing Date
2022-06-24
Accepted
2022-06-24 17:10:52
Documents
1
Group Members
AJAY ROYANMITHRIL II GP LPMITHRIL II UGP LLCPETER THIEL

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d322272dsc13da.htm SC 13D/A 97174
  Complete submission text file 0001193125-22-181642.txt   98831
Mailing Address ONE LETTERMAN DRIVE, BLDG. A, SUITE 4900 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE, BLDG. A, SUITE 4900 SAN FRANCISCO CA 94129 (415) 659-8940
MITHRIL II LP (Filed by) CIK: 0001669609 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Subject) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92804 | Film No.: 221040882
SIC: 2836 Biological Products, (No Diagnostic Substances)